This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Owens & Minor Shares Slide On Baird Downgrade

NEW YORK (AP) â¿¿ Shares of medical and surgical supply company Owens & Minor Inc. fell Wednesday after a Baird analyst downgraded the stock, citing market pressure on the sector.

THE SPARK: Baird analyst Eric Coldwell downgraded shares to "Neutral" from "Outperform" and set a $30 price target.

THE ANALYSIS: "Health care equities have been broadly punished in recent weeks and valuation is well below normal for Owens & Minor, but also for many stocks with better profiles and clearer catalysts," he said, in a note to investors.

He still views Owens & Minor as a defensive stock, but doesn't expect outperformance for the remainder of the year. He cited flat revenue expectations in 2010 because of a weak market, along with competitive pressure and pricing pressure.

"In a period of extreme health care sector pessimism and with numerous alternative investments at similar or better valuation, it is difficult to see near-term outperformance," he said.

Owens & Minor on Monday reported second-quarter profit that missed Wall Street expectations and forecast 2010 earnings at the lower end of its guidance. The company said high unemployment is affecting consumers' use of health care services, and thus use of its medical and surgical supplies.

SHARE ACTION: Down 70 cents, or 2.6 percent, to $26.38 in morning trading. The stock has traded between $25.52 and $32.80 over the last 52 weeks.

Copyright 2010 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs